New Research Insights on Achondrogenesis Treatment Overview
It is estimated that “Achondrogenesis Industry Is Expected to Grow at a CAGR 3.9% During The Forecast Period of 2017-2023.”
Achondrogenesis is a genetic rare disease that affects cartilage and bone development. The condition is characterized by narrow chest, rounded abdomen, and extremely short limbs. Achondrogenesis includes various symptoms such as, abdominal distention, flat face, anteverted nares, frontal bossing, lethal skeletal dysplasia, hydropsfetalis, abnormal enchondral ossification, and many others.
According to the U.S National Library of Medicine, the incidence of 1A and 1B, whereas achondrogenesis type 2 occur in 1 in 40,000 to 60,000 newborns. Majorly three types of achondrogenesis are known and out of these three, type 1B (ACG1B) is most severe condition. According to an article published in Gene Reviews book, it is found that SLC26A2 is the only mutated gene known to cause ACG1B.
Avail Free sample copy@ https://www.marketresearchfuture.com/sample_request/4668
Appropriate treatment for the condition is unknown but to deal with the symptoms associated with achondrogenesis, palliative care is suggested by physicians. Genetic Counseling is also recommended to the people who have genetic disorders in their family history.
Market Key Players:
Some of key the players in the Achondrogenesis Industry are –
The Achondrogenesis Industry is segmented on the basis of type, diagnosis, and end-users.
On the basis of type, market is segmented into surgery achondrogenesis type IA (Houston-Harris type), achondrogenesis type IA (Houston-Harris type), and achondrogenesis type II (Langer-Saldino type).
On the basis of diagnosis, market is classified into physical examination, molecular genetic testing, and biochemical testing. Physical examination is further classified into X-ray, ultrasound, and others. Molecular genetic testing is also further segmented into Chorionic Villus Sampling (CVS), aminocentesis, and others.
On the basis of end-users, market is segmented into hospital & clinics, diagnostic centers, research & academic institutes, and others.
Brows Complete Research Report@ https://www.marketresearchfuture.com/reports/achondrogenesis-market-4668
The Americas dominate the Achondrogenesis Industry owing to the rise in awareness among people, and high healthcare expenditure. According to the Centers for Disease Control and Prevention, in 2015, the total health expenditure in the United States was reported as USD 3.2 trillion and hospital care accounted for a share of 32.3%.
Europe holds the second position in Achondrogenesis Industry. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region.
Asia Pacific is the fastest growing Achondrogenesis Industry owing to the huge patient pool and developing healthcare technology.
The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market.
Source: Free Articles from ArticlesFactory.com
ABOUT THE AUTHOR
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312